title: Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer.
abstract: BACKGROUND
  To make a radiobiological comparison, for high risk prostate cancer (T3a, PSA > 20 ng/ml or Gleason > 7) of two radiotherapy treatment techniques. One technique consists of a treatment in three phases of the pelvic nodes, vesicles and prostate using a conventional fractionation scheme of 2 Gy/fraction (SIMRT). The other technique consists of a treatment in two phases that gives simultaneously different dose levels in each phase, 2 Gy/fraction, 2.25 Gy/fraction and 2.5 Gy/fraction to the pelvic nodes, vesicles and prostate, respectively (SIBIMRT).
  
  
  METHODS
  The equivalent dose at fractionation of 2 Gy (EQD2), calculated using the linear quadratic model with α/β prostate = 1.5 Gy, was the same for both treatment strategies. For comparison the parameters employed were D95, mean dose and Tumour Control Probabilities for prostate PTV and D15, D25, D35, D50, mean dose and Normal Tissue Complication Probabilities for the rectum and bladder, with physical doses converted to EQD2. Parameters were obtained for α/β prostate = 1.5, 3 and 10 Gy and for α/β oar = 1, 2, 3, 4, 6 and 8.
  
  
  RESULTS
  For prostate PTV, both treatment strategies are equivalent for α/β prostate = 1.5 Gy but for higher α/β prostate, EQD2 and TCP, decrease for the SIBIMRT technique. For the rectum and bladder when α/β oar ≤ 2 Gy, EQD2 and NTCP are lower for the SIMRT technique or equal in both techniques. For α/β oar ≥ 2-3 Gy, EQD2 and NTCP increase for the SIMRT treatment.
  
  
  CONCLUSIONS
  A comparison between two radiotherapy techniques is presented. The SIBIMRT technique reduces EQD2 and NTCP for α/β oar from 2 to 8 Gy.
authors.affiliation: Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
authors.forename: Trinitat García
authors.initials: TG
authors.lastname: Hernández
authors.affiliation: Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
authors.forename: Aurora Vicedo
authors.initials: AV
authors.lastname: González
authors.affiliation: Clinical Radiotherapy Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
authors.forename: Jorge Pastor
authors.initials: JP
authors.lastname: Peidro
authors.affiliation: Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
authors.forename: Juan V Roselló
authors.initials: JV
authors.lastname: Ferrando
authors.affiliation: Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
authors.forename: Luis Brualla
authors.initials: LB
authors.lastname: González
authors.affiliation: Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
authors.forename: Domingo Granero
authors.initials: DG
authors.lastname: Cabañero
authors.affiliation: Clinical Radiotherapy Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
authors.forename: José López
authors.initials: JL
authors.lastname: Torrecilla
keywords: Equivalent dose at fractionation of 2 Gy (EQD2); NTCP; Prostate; Radiobiology; Simultaneous integrated boost